Literature DB >> 22705937

A case of vulval swelling secondary to female circumcision posing a diagnostic dilemma.

Okwudili C Amu1, Emeka I Udeh, Anthony I Ugochukwu, Chukwudi Madu, Martin A Nzegwu.   

Abstract

INTRODUCTION: The practice of FGM is most prevalent in the African countries such as Nigeria, Ethiopia, Sudan, Egypt, and some area of the Middle East. It is not restricted to any ethnic, religious or socioeconomic class. There are many reasons for perpetuation of this practice; the most common are cultural and religious beliefs. The aim of this paper is to highlight the diagnostic dilemma associated with this type of case and the psychological trauma of a patient following her unfortunate genital mutilations. PRESENTATION OF CASE: We present the case of epidermal inclusion dermoid cyst in an 18-year-old teenage girl referred to us from the gynecologist as a case of hydrocoele of the canal of Nuck involving the left labia majora. Patient was previously seen by general practitioner who diagnosed a left Bartholins cyst. Excision of the mass, revealed a well encapsulated cystic mass containing serous fluid with no extension to the inguinal area, measured 10cm×8cm. Histology showed epidermoid inclusion dermoid cyst probably related to circumcision (female genital mutilation). DISCUSSION: Implantation dermoid cyst though a recognized complication of FGM is rare in our environment and a high index of suspicion is required any time a girl presents with a vulval swelling. Cosmesis still remains the watchword to assuage the psychological impact on the patient.
CONCLUSION: There is need for more public health campaigns to educate communities about the harms of circumcision with the goal of eradicating the practice.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22705937      PMCID: PMC3397301          DOI: 10.1016/j.ijscr.2012.03.038

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  15 in total

1.  The risk of medical complications after female circumcision.

Authors:  M A Dirie; G Lindmark
Journal:  East Afr Med J       Date:  1992-09

2.  Female genital mutilation in rural Ghana, west Africa.

Authors:  A Odoi; S P Brody; T E Elkins
Journal:  Int J Gynaecol Obstet       Date:  1997-02       Impact factor: 3.561

Review 3.  Female genital mutilation.

Authors:  E F Fox; A de Ruiter; J S Bingham
Journal:  Int J STD AIDS       Date:  1997-10       Impact factor: 1.359

4.  A traditional practice that threatens health--female circumcision.

Authors: 
Journal:  WHO Chron       Date:  1986

5.  Female genital mutilation in Britain.

Authors:  J A Black; G D Debelle
Journal:  BMJ       Date:  1995-06-17

6.  Female circumcision as a public health issue.

Authors:  N Toubia
Journal:  N Engl J Med       Date:  1994-09-15       Impact factor: 91.245

7.  Complications of female circumcision in the Sudan.

Authors:  A El Dareer
Journal:  Trop Doct       Date:  1983-07       Impact factor: 0.731

8.  Clitoral epidermoid cyst secondary to blunt trauma in a 9-year-old child.

Authors:  Neslihan Celik; Sule Yalçin; Safak Güçer; Ibrahim Karnak
Journal:  Turk J Pediatr       Date:  2011 Jan-Feb       Impact factor: 0.552

9.  Female genital mutilation. Council on Scientific Affairs, American Medical Association.

Authors: 
Journal:  JAMA       Date:  1995-12-06       Impact factor: 56.272

Review 10.  Epidermal inclusion cysts of the clitoris as a complication of female circumcision and pharaonic infibulation.

Authors:  M G Hanly; V J Ojeda
Journal:  Cent Afr J Med       Date:  1995-01
View more
  2 in total

1.  Hydrocele of the canal of Nuck presenting as a sausage-shaped mass.

Authors:  Ana Filipa Ferreira; João Paulo Marques; Francisco Falcão
Journal:  BMJ Case Rep       Date:  2017-10-04

Review 2.  Addressing Female Genital Mutilation/Cutting (FGM/C) in the Era of Clitoral Reconstruction: Plastic Surgery.

Authors:  Hannes Sigurjonsson; Malin Jordal
Journal:  Curr Sex Health Rep       Date:  2018-04-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.